首页> 外文OA文献 >Efficacy and safety of the fixed‐ratio combination of insulin degludec and liraglutide by baseline glycated hemoglobin, body mass index and age in Japanese individuals with type 2 diabetes: A subgroup analysis of two phase III trials

【2h】

Efficacy and safety of the fixed‐ratio combination of insulin degludec and liraglutide by baseline glycated hemoglobin, body mass index and age in Japanese individuals with type 2 diabetes: A subgroup analysis of two phase III trials

机译：胰岛素Degludec和Liraglutide的固定比率组合通过基线糖化血红蛋白，男性群体指数和2型糖尿病患者的疗效和安全性：两期III试验的亚组分析

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

著录项
引文网络
相似文献
相关主题

著录项

作者
Mitsuhisa Komatsu; Hirotaka Watada; Shizuka Kaneko; Bue F Ross Agner; Tomoyuki Nishida; Kohei Kaku;
展开▼
作者单位

展开▼
年度 2021
总页数
原文格式 PDF
正文语种
中图分类

相似文献

外文文献

1. Superior efficacy with a fixed‐ratio combination of insulin degludec and liraglutide (IDegLira) compared with insulin degludec and liraglutide in insulin‐na?ve Japanese patients with type 2 diabetes in a phase 3, open‐label, randomized trial [J] . Kaku Kohei, Araki Eiichi, Tanizawa Yukio, Diabetes, obesity & metabolism . 2019,第12期

机译：与胰岛素Degludec和Liragludec和Liraglutide在胰岛素-Na've的胰岛素Degludec和Liraglutide中的胰岛素-Na've日本患者的胰岛素Degludec和Liraglutide的卓越疗效卓越的疗效与第3型糖尿病患者，开放标签，随机试验
2. Superior HbA1c control with the fixed‐ratio combination of insulin degludec and liraglutide (IDegLira) compared with a maximum dose of 50?units of insulin degludec in Japanese individuals with type 2 diabetes in a phase 3, double‐blind, randomized trial [J] . Watada Hirotaka, Kaneko Shizuka, Komatsu Mitsuhisa, Diabetes, obesity & metabolism . 2019,第12期

机译：优质的HBA1C控制与胰岛素Degludec和Liraglutide（IDEGLIRA）的固定比例组合，与最大剂量为50岁？在第3期患有2型糖尿病的日本人中胰岛素Degludec的单位，双盲，随机试验
3. The co-formulation of insulin degludec and insulin aspart lowers fasting plasma glucose and rates of confirmed and nocturnal hypoglycaemia, independent of baseline glycated haemoglobin levels, disease duration or body mass index: A pooled meta-analysis of phase III studies in patients with type 2 diabetes [J] . Haluzik Martin, Fulcher Greg, Pieber Thomas R., Diabetes, obesity & metabolism . 2018,第7期

机译：胰岛素Degludec和胰岛素Aspart的共同制剂降低了禁食血浆葡萄糖和确诊和夜间低血糖血症的速率，与基线糖化血红蛋白水平，疾病持续时间或体重指数无关：2型患者III期研究的合并的荟萃分析糖尿病
4. The relationship between the emotional burden of Type 2 Diabetes and glycemic control and differences in emotional burden and glycemic control among individuals treated with oral antidiabetic agents, combination therapy, incretin mimetic, and insulin [D] . Douaihy, Katharine 2008

机译：2型糖尿病患者的情绪负担与血糖控制之间的关系以及口服抗糖尿病药，联合疗法，降钙素模拟物和胰岛素治疗的个体之间情绪负担和血糖控制的差异
5. The co‐formulation of insulin degludec and insulin aspart lowers fasting plasma glucose and rates of confirmed and nocturnal hypoglycaemia independent of baseline glycated haemoglobin levels disease duration or body mass index: A pooled meta‐analysis of phase III studies in patients with type 2 diabetes [O] . Martin Haluzík, Greg Fulcher, Thomas R. Pieber, -1

机译：地格曲胰岛素和门冬胰岛素的共同配方可降低空腹血糖确诊和夜间低血糖发生率而与基线糖化血红蛋白水平疾病持续时间或体重指数无关：对2型患者进行的III期研究汇总荟萃分析糖尿病
6. Superior efficacy with a fixed‐ratio combination of insulin degludec and liraglutide (IDegLira) compared with insulin degludec and liraglutide in insulin‐naïve Japanese patients with type 2 diabetes in a phase 3, open‐label, randomized trial [O] . Kohei Kaku, Eiichi Araki, Yukio Tanizawa, 2019

机译：与胰岛素Degludec和Liraglutide（IDEGLIRA）的胰岛素Degludec和Liraglutide在胰岛素-Naïve日本患者中的胰岛素Degludec和Liraglutide中的胰岛素-Naïve，在第3型糖尿病中，开放标签，随机试验

Efficacy and safety of the fixed‐ratio combination of insulin degludec and liraglutide by baseline glycated hemoglobin, body mass index and age in Japanese individuals with type 2 diabetes: A subgroup analysis of two phase III trials

著录项

引文网络

相似文献

相关主题

期刊订阅